Do Mucus-Clearing Treatments Really Work? A Look at the Evidence (and the Myths)

I’ve been a respiratory therapist for 28 years and 4 days. Hard to believe it’s been that long. I remember learning about hypertonic saline in RT school back in ’96. By the time I hit the floors in ’97, it was already out of style — “proven useless.”

Now?

It’s back with a vengeance. I see it ordered almost every day for… whatever disease of the week.

Same with CPT.

We used to pound on the chests of every post-op patient as if soreness alone was a mucus diagnosis. Eventually studies caught up and said, “yeah… this doesn’t actually do anything.” Plus, hitting fragile 85-year-old ribs? Maybe not our best era.

Mucomyst has always been the strange child. Ordered for people who “can’t bring up secretions,” or because a doctor thinks “it’ll help.” And of course the whole room ends up smelling like rotten eggs. The only people who don’t mind are the ones so old they don’t care about anything anymore — including their own room smelling like poop, as their comode sits filled in the corner.

And after this many years in the job, you learn the difference between:

something that actually works
and
something that looks like work.

Hypertonic saline. Pulmozyme. Mucomyst. The Vest. Acapella. CPT.

We’ve all done them. We’ve all questioned them.

Some days you walk into a patient’s room and they have everything ordered. If I actually did all of it by the book, I’d be in the room for two straight hours. No thanks. Nobody’s got that kind of time.

And eventually the question creeps in:

Does any of this actually help the patient?

Or are we just doing it because we've always done it?

So I dug through the research — real numbers, solid studies, repeatable results. Because one study is not science, guys. Science is when multiple studies show the same thing again and again — and even then, people still argue about it. That’s real science. And honestly, the reason we debate it is because only God knows the full truth — we’re just here trying to figure out our tiny piece of it.

Here’s what actually holds up.

---

CYSTIC FIBROSIS

The only place where mucus therapy truly delivers — even if the gains are smaller than you think.

Hypertonic Saline (3–7%)

• FEV₁ improves ~3%

• Exacerbations drop ~50%

• Good, repeatable evidence

• Helps clear mucus and improves sleep

Pulmozyme (Dornase Alfa)

• FEV₁ improves 5–12%

• Fewer infections

• Slows long-term decline

The Vest

• Works about the same as solid manual CPT

• FEV₁ improves 1–3%

• Reliable long-term airway clearance

Now here’s the part no one says out loud:

"If Pulmozyme improves FEV₁ 5–12%, that means, in 88–95% of patients, of lung function does not change.

CF is the condition where these therapies shine — and even there, the gains are modest.

Still worth it. Still life-extending. Just not magic.

---

BRONCHIECTASIS (Non-CF)

Helpful, but not groundbreaking.

OPEP Devices (Acapella, Aerobika, PEP)

• Patients feel less congested

• Increased sputum production

• FEV₁ improves 1–3% (which also means it does absolutely nothing in the other 97–99% of cases).

• Some studies show 10–20% fewer exacerbations (So in 80-90% of cases it has no effect)

The Vest

• Helps move mucus

• Patients feel better

• Minimal FEV₁ impact

Bottom line:
Therapies help people feel better and cough more effectively —
but they barely move the pulmonary function numbers.

---

THE VEST (General Use)

It looks dramatic. It sounds dramatic.
It helps the right patients — but it’s ordered for the wrong ones just as often.

Good for:

• CF

• Bronchiectasis

• Chronic heavy secretions

Not good for:

• Most COPD patients

• Pneumonia

• Mild secretions

• People who just “have rhonchi”

The Vest does not:

• Improve oxygenation

• Shorten hospital stays

A lot of doctors order it because it feels like “doing something.”
The evidence does not back that up for most inpatients.

---

COPD

The land where tradition rules over data.

Most COPD orders look like this:

• Mucomyst

• Acapella

• Light CPT

• Maybe the Vest (usually pointless)

Mucomyst (NAC Neb)

We all know it thins mucus.
But when you actually look at outcomes?

• No meaningful FEV₁ change

• No better oxygenation

• No reduction in hospitalizations

• Bronchospasm 10–20%

• Studies are old and weak

Translation:
Mucomyst for COPD is 90% tradition, 10% actual effect.

And the smell?
Rotten eggs. Every time.

Acapella / Aerobika

This actually does something.

• Helps mobilize mucus

• Patients feel better after using it

• FEV₁ changes 0–2%

• Some studies: 10–30% fewer COPD readmissions

Not a miracle — but useful.

The Vest (in COPD)

The research says:

• Helps the small handful of COPD patients with lots of mucus

• Does little to nothing for the majority

• No significant FEV₁ improvement

• No consistent length-of-stay improvement

80–90% of COPD patients get almost no benefit.

Yet it still gets ordered on autopilot.

---

PNEUMONIA

If we’re doing airway clearance here, we’re doing it for comfort — not cure.

Research shows:

• Chest PT does not cure pneumonia faster

• Vest does not improve oxygenation

• OPEP does not reduce mortality

• ACT does not reduce complications

• Does not shorten length of stay

The only tiny benefit?
A couple small studies suggest fever may break 12 hours sooner.

That’s it.

---

NEUROMUSCULAR & SPINAL CORD INJURY

Finally — a therapy that actually does exactly what it should.

CoughAssist / MIE

• Increases cough flow 50–150%

• Prevents mucus plugging

• Cuts pneumonia risk

• Reduces intubations

• Reduces hospitalizations

These patients don’t have a mucus problem —
they have a weak cough problem.

This device is a game-changer.

---

THE BOTTOM LINE

After almost three decades doing this job, this is the simplest way I can put it:

Some therapies help a lot.
Some help a little.
Some don’t help much at all.

But tradition sticks around forever.

And some days, when you’re dragging a Vest into the room of a COPD patient who hasn’t coughed anything up since 2003, you can feel the gap between what we know and what we’re ordered to do.

Here’s the honest breakdown:

STRONG EVIDENCE

• Pulmozyme (CF)

• Hypertonic saline (CF)

• CoughAssist (NMD, spinal injury)

MODERATE EVIDENCE

• Acapella / Aerobika

• OPEP for bronchiectasis

• The Vest for CF & bronchiectasis

WEAK EVIDENCE

• Mucomyst for COPD

• The Vest for COPD

• Chest PT for pneumonia

• OPEP for pneumonia

ALMOST NO EVIDENCE

• “We have to order something.”

I’m not trying to stir drama. I love respiratory care.
But I also like knowing the difference between what works and what’s just habit.

And honestly?

If a therapy only helps 10% of patients,
that means 90% of the time we’re basically doing busywork.
That’s not bad RT care — it’s just the reality of old habits in medicine.

And that’s why asking questions matters.